Clinical Trial Update: Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

View source ↗

Summary

A recruiting clinical trial evaluating the efficacy and safety of telitacicept in combination with baricitinib for refractory rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)
• Telitacicept

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Telitacicept, Treatment Compliance | Status: RECRUITING